Press "Enter" to skip to content

New patent expiration for Ferrer Internacional drug XEPI

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Ferrer Internacional drug XEPI

Annual Drug Patent Expirations for XEPI
Annual Drug Patent Expirations for XEPI

Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.

This drug has forty-four patent family members in twenty-five countries.

The generic ingredient in XEPI is ozenoxacin. Two suppliers are listed for this compound. Additional details are available on the ozenoxacin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Ferrer Internacional drug XEPI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions